The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Institutions: Oslo University Hospital, University of Oslo, University of Nottingham, University of Copenhagen, Bispebjerg Hospital, Vilnius University, Vilnius University Hospital Santariskiu Klinikos, Tartu University Hospital, St. Josefs-Hospital Cloppenburg, University of Edinburgh, Institute of Psychiatry and Neurology, Turku University Hospital, Uppsala University, Universitair Ziekenhuis Leuven
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2123312526
